Understanding the risk factors for adenomyosis progression
Risk Factors Associated With The Progression Of Adenomyosis
This study is trying to find out what factors might make adenomyosis worse over time in women aged 18 to 55 who show signs of the condition on ultrasound.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 258 (estimated) |
| Ages | 18 Years to 55 Years |
| Sex | Female |
| Sponsor | IRCCS Azienda Ospedaliero-Universitaria di Bologna Academic / other |
| Locations | 1 site (Bologna) |
| Trial ID | NCT06718088 on ClinicalTrials.gov |
What this trial studies
This observational study aims to investigate the risk factors associated with the progression of adenomyosis, a common gynecological disorder affecting women of childbearing age. Utilizing transvaginal ultrasound (TVUS) as the primary diagnostic tool, the study will assess the natural course of adenomyosis and identify factors that may influence its progression over time. Participants will be women aged 18 to 55 who exhibit specific ultrasound signs of adenomyosis, and the study will gather data to enhance understanding of this condition.
Who should consider this trial
Good fit: Ideal candidates for this study are women aged 18 to 55 with ultrasound-confirmed signs of adenomyosis.
Not a fit: Patients who have undergone hysterectomy or have recent pregnancy or childbirth may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved management strategies for women suffering from adenomyosis.
How similar studies have performed: While there have been studies on hormonal treatments for adenomyosis, this investigation into the progression and risk factors is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients aged between 18 and 55 years; * Presence of at least two direct and indirect signs according to the MUSA classification * Obtaining informed consent Exclusion Criteria: * Patients undergoing hysterectomy; * Virgo patients; * Patients reporting intolerance to transvaginal ultrasound; * Gynaecological oncology; * Recent pregnancy or childbirth (within 6 months)
Where this trial is running
Bologna
- IRCCS Azienda Ospedaliero-Universitaria di Bologna — Bologna, Italy (Recruiting)
Study contacts
- Principal investigator: Paolo Casadio, MD — IRCCS Azienda Ospedaliero-Universitaria di Bologna
- Study coordinator: Paolo Casadio, MD
- Email: paolo.casadio@aosp.bo.it
- Phone: +390512144411
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.